ÂÜÀòÂÒÂ×

Antoine Pechin is an accomplished finance professional currently serving as a Board Member at HotHouse Therapeutics, Resurrect Bio, and L Marks, along with holding the position of Investment Director at SynBioVen since January 2022. With a long-standing role as Partner at Winton since May 2015, Antoine also managed early-stage investments and vendor management initiatives within Winton Ventures. Additional experience includes serving as a Board Observer for multiple companies, including Hoxton Analytics, CyberSmart, and Exonar. Antoine Pechin holds a Master's degree in Finance from EDHEC Business School, completed between 2004 and 2008.